2014 Dec 08
Promising results for Lenalidomide-Rituximab treatment in mantle cell lymphoma
Jia Ruan, M.D., Ph.D., talks to OncLive about the results of a phase II study that show sustained remissions experienced by patients treated with the combination of lenalidomide and rituximab as initial treatment for mantle cell lymphoma (MCL). Read more